AntiAngioPred

AntiAngioPred predicts anti-angiogenic peptides to identify peptide sequences that inhibit angiogenesis for cancer therapeutic research.

Key Features:

• Residue Preference Analysis: Reports residue preferences observed in known anti-angiogenic peptides, including favored Cys, Pro, Ser, Arg, Trp, Thr, Gly and disfavored Ala, Asp, Ile, Leu, Val, Phe.
• Positional Preference: Identifies positional preferences such as enrichment of Ser, Pro, Trp, Cys in N-terminal regions and Cys, Gly, Arg in C-terminal regions.
• Motif Analysis: Detects prominent sequence motifs including "CG-G", "TC", "SC", and "SP-S" associated with anti-angiogenic activity.
• Machine Learning Models: Employs machine learning algorithms using amino acid composition to build prediction models achieving up to 80.9% accuracy and a Matthews Correlation Coefficient (MCC) of 0.62.
• Independent Dataset Validation: Validates model performance using independent datasets.

Scientific Applications:

• Cancer Research: Identifies peptides that can inhibit angiogenesis to support research into anti-cancer therapies.
• Drug Design: Provides sequence and motif insights to facilitate rational design of peptide-based therapeutics targeting angiogenic pathways.
• Bioinformatics Studies: Supports analysis of peptide characteristics, residue preferences, and motif patterns related to anti-angiogenic function.

Methodology:

Analyzes residue preferences, positional tendencies, and motifs and applies machine learning-based predictive modeling validated on independent datasets.